ConductScience.org, home

Paper6234474

Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes.

Mann DM and 2 others. Neuropathol Appl Neurobiol, 1984. Cited by 316 papers, by iCite.

Cite this record

ConductScience Library. Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes. Papers, record 6234474. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6234474

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes.
PubMed
Journal
Neuropathol Appl Neurobiol
PubMed
Year
1984
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
316
iCite
Relative citation ratio, by iCite
8.61
iCite
Revised in PubMed
2019-09-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mann DMD M
2Yates POP O
3Marcyniuk BB

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AgingMajor topic
Alzheimer DiseaseMajor topic
Down SyndromeMajor topic
Aged
Cell Count
Cell Nucleolus
Cerebral Cortex
Female
Humans
Locus Coeruleus
Male
Middle Aged
Neurofibrils
Raphe Nuclei
Substantia Innominata

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT07531940Escalating Doses of Memantine in Down Syndrome (MEDS-123)Background

Source ClinicalTrials.gov

Download CSV of trials

Cited by85

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 316 citations.

PMIDTitleJournalYearIn PapersSource
42488757Distinct brain regions are affected by neurodevelopmental or pre-dementia changes in Down syndrome.Brain Commun2026https://conductscience.org/library/papers/42488757PubMed
42196596Glial Cells in Behavioral and Psychological Symptoms of Alzheimer's Disease.Int J Mol Sci2026https://conductscience.org/library/papers/42196596PubMed
41930605Maternal Choline Supplementation in a Mouse Model of Down Syndrome and Alzheimer's Disease Generates Unique Expression Profile Mosaics Within Three Hippocampal Excitatory Neuronal Populations.FASEB J2026https://conductscience.org/library/papers/41930605PubMed
41074907Development and evaluation of image preprocessing pipelines for the Centiloid method on Down Syndrome data.Alzheimers Dement2025https://conductscience.org/library/papers/41074907PubMed
40867575Benefits of Maternal Choline Supplementation on Aged Basal Forebrain Cholinergic Neurons (BFCNs) in a Mouse Model of Down Syndrome and Alzheimer's Disease.Biomolecules2025https://conductscience.org/library/papers/40867575PubMed
40078964Profiling hippocampal neuronal populations reveals unique gene expression mosaics reflective of connectivity-based degeneration in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.Front Mol Neurosci2025https://conductscience.org/library/papers/40078964PubMed
39880902The genetics of neurodegenerative diseases is the genetics of age-related damage clearance failure.Mol Psychiatry2025https://conductscience.org/library/papers/39880902PubMed
39605035Down syndrome frontal cortex layer III and layer V pyramidal neurons exhibit lamina specific degeneration in aged individuals.Acta Neuropathol Commun2024https://conductscience.org/library/papers/39605035PubMed
39595846On the Therapeutic Use of Monoclonal Antibodies Against Amyloid Plaques in Older Adults with Down Syndrome: A Narrative Review and Perspective.Brain Sci2024https://conductscience.org/library/papers/39595846PubMed
39331291Monoamine alterations in Alzheimer's disease and their implications in comorbid neuropsychiatric symptoms.Geroscience2025https://conductscience.org/library/papers/39331291PubMed
39105932Analysis of microisolated frontal cortex excitatory layer III and V pyramidal neurons reveals a neurodegenerative phenotype in individuals with Down syndrome.Acta Neuropathol2024https://conductscience.org/library/papers/39105932PubMed
39031371Hippocampal CA1 Pyramidal Neurons Display Sublayer and Circuitry Dependent Degenerative Expression Profiles in Aged Female Down Syndrome Mice.J Alzheimers Dis2024https://conductscience.org/library/papers/39031371PubMed
38623383From understanding to action: Exploring molecular connections of Down syndrome to Alzheimer's disease for targeted therapeutic approach.Alzheimers Dement (Amst)2024https://conductscience.org/library/papers/38623383PubMed
37191946Basal forebrain cholinergic neurons are vulnerable in a mouse model of Down syndrome and their molecular fingerprint is rescued by maternal choline supplementation.FASEB J2023https://conductscience.org/library/papers/37191946PubMed
37115753What does heritability of Alzheimer's disease represent?PLoS One2023https://conductscience.org/library/papers/37115753PubMed
35747206Rodent Modeling of Alzheimer's Disease in Down Syndrome: In vivo and ex vivo Approaches.Front Neurosci2022https://conductscience.org/library/papers/35747206PubMed
35532913Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical Trial.JAMA Neurol2022https://conductscience.org/library/papers/35532913PubMed
35517047Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer's Disease.Front Aging Neurosci2022https://conductscience.org/library/papers/35517047PubMed
34990205Prenatal and Postnatal Pharmacotherapy in Down Syndrome: The Search to Prevent or Ameliorate Neurodevelopmental and Neurodegenerative Disorders.Annu Rev Pharmacol Toxicol2022https://conductscience.org/library/papers/34990205PubMed
34682809Aging with Down Syndrome-Where Are We Now and Where Are We Going?J Clin Med2021https://conductscience.org/library/papers/34682809PubMed

See all 85 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6234474

GET https://conductscience.org/api/papers/v1/6234474/cited_by?page=2